Document is current
Any future updates will be listed below
-
Authors
O’Neill, Alexandra G.
Pax, Melissa
Parent, Jourdan H.
Sepulcre, Jorge
Camprodon, Joan A.
Noble, Stephanie
Roffman, Joshua L.
Eryilmaz, Hamdi
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AG061811, R00MH130894, K01MH116369)
- License Information
-
More Information
Article History
Received: 21 October 2024
Revised: 2 May 2025
Accepted: 12 May 2025
First Online: 4 June 2025
Competing interests
: JAC is an inventor on patents and patent applications on neuromodulation targeting methods held by Massachusetts General Hospital. He is a member of the scientific advisory board of Hyka and Flow Neuroscience, and has been a paid consultant for Neuronetics, Mifu Technologies, Neuroelectrics, and LivaNova. All other authors report no financial interests or potential conflicts of interest.
